Aura Biosciences AURA
NASDAQ AURA
$7.61 -0.04 (-0.52%)
At close: Nov 11, 2026 · 4:00 PM EST

Aura Biosciences (AURA) Preferred Stock Liabilities (2020 - 2021)

Updated

Aura Biosciences (AURA) recorded Preferred Stock Liabilities of $312.98 million in Q3 2021, up 164.9% from $118.17 million a year earlier and up 45.4% from the prior quarter.

Analysis

Aura Biosciences (AURA) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends

At the end of FY2020, Aura Biosciences reported Preferred Stock Liabilities of $128.08 million.

  • Per Business Quant, the preceding three quarters came in at $215.3 million (Q2 2021), $215.3 million (Q1 2021) and $128.08 million (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Aura Biosciences 796.17 Mn 542.36 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 312.98 Mn
Jun 30, 2021 215.30 Mn
Mar 31, 2021 215.30 Mn
Dec 31, 2020 128.08 Mn
Sep 30, 2020 118.17 Mn
API Access

Aura Biosciences Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=AURA&period=max&api_key=YOUR_API_KEY